Behavioral Dysfunctions After Preterm Birth: The Role of Vasopressin

This project aims to explore the role of arginine vasopressin (AVP) in cognitive and anxiety-like behavior dysfunctions observed in preterm birth models. Using a neonatal hyperoxia rat model, which mimics bronchopulmonary dysplasia (BPD) and associated complications of preterm birth, the study will assess behavioral outcomes and AVP levels in different experimental conditions. The findings are expected to clarify the mechanisms linking elevated AVP to behavior dysfunctions, paving the way for targeted therapies to improve long-term neurological and emotional outcomes in preterm individuals. Participating institutions will benefit from advancing knowledge in neonatal care, fostering collaborative research, and contributing to innovative solutions for preterm health challenges.

Faculty Supervisor:

Anne Monique Nuyt

Student:

Partner:

Universidade Federal de Minas Gerais

Discipline:

Life Sciences

Sector:

Education

University:

Université de Montréal

Program: